The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations
Open accessAbstract
Cancer is a disease of the genome caused by oncogene activation and tumor suppressor gene inhibition. Deep sequencing studies including large consortia such as TCGA and ICGC identified numerous tumor-specific mutations not only in protein-coding sequences but also in non-coding sequences. Although 98% of the genome is not translated into proteins, most studies have neglected the information hidden in this "dark matter" of the genome. Malignancy-driving mutations can occur in all genetic elements outside the coding region, namely in enhancer, silencer, insulator, and promoter as well as in 5'-UTR and 3'-UTR Intron or splice site mutations can alter the splicing pattern. Moreover, cancer genomes contain mutations within non-coding RNA, such as microRNA, lncRNA, and lincRNA A synonymous mutation changes the coding region in the DNA and RNA but not the protein sequence. Importantly, oncogenes such as TERT or miR-21 as well as tumor suppressor genes such as TP53/p53, APC, BRCA1, or RB1 can be affected by these alterations. In summary, coding-independent mutations can affect gene regulation from transcription, splicing, mRNA stability to translation, and hence, this largely neglected area needs functional studies to elucidate the mechanisms underlying tumorigenesis. This review will focus on the important role and novel mechanisms of these non-coding or allegedly silent mutations in tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions
Huang, W., Thomas, B., Flynn, R. A., Gavzy, S. J., Wu, L., Kim, S. V., Hall, J. A., Miraldi, E. R., Ng, C. P., Rigo, F., et al. (2015) · Nature · doi:10.1038/nature16193 · Cited by 167
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · cited 1×
“Research of the last decades confirmed this hypothesis and deepened our understanding of the genomic landscape of cancer (Alexandrov et al , 2013; Weinstein et al , 2013).”
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871 · cited 1×
“Also epigenetic events and infectious agents as the human papillomavirus can have a tumorigenic effect, but these are beyond the scope of this review (zur Hausen, 2009; Baylin & Jones, 2011).”
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Many roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Self-citationA "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206928 · Cited by 2,189
Self-citationThe hallmarks of cancer: A long non-coding RNA point of view
Gutschner, T., & Diederichs, S. (2012) · RNA Biology · doi:10.4161/rna.20481 · Cited by 1,802
Self-citationTERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
The Emergence of lncRNAs in Cancer Biology
Prensner, J. R., & Chinnaiyan, A. M. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0209 · Cited by 1,770
A germline-specific class of small RNAs binds mammalian Piwi proteins
Girard, A., Sachidanandam, R., Hannon, G. J., & Carmell, M. A. (2006) · Nature · doi:10.1038/nature04917 · Cited by 1,762
Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Targeting microRNAs in cancer: rationale, strategies and challenges
Garzon, R., Marcucci, G., & Croce, C. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3179 · Cited by 1,493
The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Gutschner, T., Hämmerle, M., Eißmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Groß, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2850 · Cited by 1,415
Self-citationKrawczak, M., Reiss, J., & Cooper, D. (1992) · Human Genetics · doi:10.1007/bf00210743 · Cited by 1,324
Genetic variation in microRNA networks: the implications for cancer research
Ryan, B. M., Robles, A. I., & Harris, C. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2867 · Cited by 1,257
SPLICING OF MESSENGER RNA PRECURSORS
Padgett, R. A., Grabowski, P. J., Konarska, M. M., Seiler, S., & Sharp, P. A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.005351 · Cited by 1,223
The human splicing code reveals new insights into the genetic determinants of disease
Xiong, H. Y., Alipanahi, B., Lee, L. J., Bretschneider, H., Merico, D., Yuen, R. K. C., Hua, Y., Gueroussov, S., Najafabadi, H. S., Hughes, T. R., et al. (2015) · Science · doi:10.1126/science.1254806 · Cited by 1,220
Mistranslation-Induced Protein Misfolding as a Dominant Constraint on Coding-Sequence Evolution
Drummond, D. A., & Wilke, C. O. (2008) · Cell · doi:10.1016/j.cell.2008.05.042 · Cited by 1,053
Splicing in disease: disruption of the splicing code and the decoding machinery
Wang, G.-S., & Cooper, T. A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2164 · Cited by 1,050
Understanding the contribution of synonymous mutations to human disease
Sauna, Z. E., & Kimchi-Sarfaty, C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3051 · Cited by 1,022
From Birth to Death: The Complex Lives of Eukaryotic mRNAs
Moore, M. J. (2005) · Science · doi:10.1126/science.1111443 · Cited by 1,010
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3166 · Cited by 936
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
Leiserson, M. D. M., Vandin, F., Wu, H.-T., Dobson, J. R., Eldridge, J. V., Thomas, J. L., Papoutsaki, A., Kim, Y., Niu, B., McLellan, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3168 · Cited by 903
Frequency of TERT promoter mutations in human cancers
Vinagre, J., Almeida, A., Pópulo, H., Batista, R., Lyra, J., Pinto, V., Coelho, R., Celestino, R., Prazeres, H., Lima, L., et al. (2013) · Nature Communications · doi:10.1038/ncomms3185 · Cited by 898
Splicing of Messenger RNA Precursors
SHARP, P. A., HARDY, S., & PADGETT, R. A. (1984) · Transfer ‖ Expression of Eukaryotic Genes · doi:10.1016/b978-0-12-284650-2.50023-7 · Cited by 862
Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., Maixner, W., & Diatchenko, L. (2006) · Science · doi:10.1126/science.1131262 · Cited by 848
Klein, U., Lia, M., Crespo, M., Siegel, R., Shen, Q., Mo, T., Ambesi-Impiombato, A., Califano, A., Migliazza, A., Bhagat, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.019 · Cited by 848
Dissecting the genomic complexity underlying medulloblastoma
Jones, D. T. W., Jäger, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.-J., Pugh, T. J., Hovestadt, V., Stütz, A. M., et al. (2012) · Nature · doi:10.1038/nature11284 · Cited by 839
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Beà, S., Valdés-Mas, R., Villamor, N., Gutiérrez-Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2015) · Nature · doi:10.1038/nature14666 · Cited by 829
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Mansour, M. R., Abraham, B. J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A. D., Etchin, J., Lawton, L., Sallan, S. E., Silverman, L. B., et al. (2014) · Science · doi:10.1126/science.1259037 · Cited by 801 · cited 1×
“Thereby, a large regulatory element, a so-called “super-enhancer”, is created leading to the overexpression of the oncogene TAL1 (Mansour et al , 2014).”
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Totoki, Y., Tatsuno, K., Covington, K. R., Ueda, H., Creighton, C. J., Kato, M., Tsuji, S., Donehower, L. A., Slagle, B. L., Nakamura, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3126 · Cited by 781
Pott, S., & Lieb, J. D. (2015) · Nature Genetics · doi:10.1038/ng.3167 · Cited by 761
Xing, M., Liu, R., Liu, X., Murugan, A. K., Zhu, G., Zeiger, M. A., Pai, S., & Bishop, J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5094 · Cited by 725
Yang, Z., Zhou, L., Wu, L.-M., Lai, M.-C., Xie, H.-Y., Zhang, F., & Zheng, S.-S. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1581-y · Cited by 708
Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution
KIMURA, M. (1977) · Nature · doi:10.1038/267275a0 · Cited by 703
Human polymorphism at microRNAs and microRNA target sites
Saunders, M. A., Liang, H., & Li, W.-H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611347104 · Cited by 654
Long Intergenic Noncoding RNAs: New Links in Cancer Progression
Tsai, M.-C., Spitale, R. C., & Chang, H. Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2483 · Cited by 641
Chin, L. J., Ratner, E., Leng, S., Zhai, R., Nallur, S., Babar, I., Muller, R.-U., Straka, E., Su, L., Burki, E. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2129 · Cited by 632
Yu, C.-H., Dang, Y., Zhou, Z., Wu, C., Zhao, F., Sachs, M. S., & Liu, Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.018 · Cited by 619
Boveri, T. (2008) · Journal of Cell Science · doi:10.1242/jcs.025742 · Cited by 573
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Bell, R. J. A., Rube, H. T., Kreig, A., Mancini, A., Fouse, S. D., Nagarajan, R. P., Choi, S., Hong, C., He, D., Pekmezci, M., et al. (2015) · Science · doi:10.1126/science.aab0015 · Cited by 566
Brest, P., Lapaquette, P., Souidi, M., Lebrigand, K., Cesaro, A., Vouret-Craviari, V., Mari, B., Barbry, P., Mosnier, J.-F., Hébuterne, X., et al. (2011) · Nature Genetics · doi:10.1038/ng.762 · Cited by 563
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Supek, F., Miñana, B., Valcárcel, J., Gabaldón, T., & Lehner, B. (2014) · Cell · doi:10.1016/j.cell.2014.01.051 · Cited by 557
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Beà, S., Valdés-Mas, R., Villamor, N., Gutiérrez-Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2016) · Nature · doi:10.1038/nature18910 · Cited by 546
Gene Expression Regulation by Upstream Open Reading Frames and Human Disease
Barbosa, C., Peixeiro, I., & Romão, L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003529 · Cited by 525
Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA
Duan, R., Pak, C., & Jin, P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm062 · Cited by 497
Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
Kong-Beltran, M., Seshagiri, S., Zha, J., Zhu, W., Bhawe, K., Mendoza, N., Holcomb, T., Pujara, K., Stinson, J., Fu, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2749 · Cited by 490
Genome-wide analysis of noncoding regulatory mutations in cancer
Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484
Annotating non-coding regions of the genome.
Alexander, R. P., Fang, G., Rozowsky, J., Snyder, M., & Gerstein, M. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2814 · Cited by 464
Hunt, R. C., Simhadri, V. L., Iandoli, M., Sauna, Z. E., & Kimchi-Sarfaty, C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.006 · Cited by 389
Sparago, A., Cerrato, F., Vernucci, M., Ferrero, G. B., Silengo, M. C., & Riccio, A. (2004) · Nature Genetics · doi:10.1038/ng1410 · Cited by 371
Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.
Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B. H., Knowles, D. M., Offit, K., Chaganti, R. S., & Dalla-Favera, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12520 · Cited by 354
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Oldridge, D. A., Wood, A. C., Weichert-Leahey, N., Crimmins, I., Sussman, R., Winter, C., McDaniel, L. D., Diamond, M., Hart, L. S., Zhu, S., et al. (2015) · Nature · doi:10.1038/nature15540 · Cited by 301
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
Swedish Low-risk Colorectal Cancer Study Group, Stacey, S. N., Sulem, P., Jonasdottir, A., Masson, G., Gudmundsson, J., Gudbjartsson, D. F., Magnusson, O. T., Gudjonsson, S. A., Sigurgeirsson, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.926 · Cited by 295
Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
Liu, L., Dilworth, D., Gao, L., Monzon, J., Summers, A., Lassam, N., & Hogg, D. (1999) · Nature Genetics · doi:10.1038/5082 · Cited by 276
Kinde, I., Munari, E., Faraj, S. F., Hruban, R. H., Schoenberg, M., Bivalacqua, T., Allaf, M., Springer, S., Wang, Y., Diaz, L. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2498 · Cited by 253
Wiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K., Liu, H., Rosenwald, A., Muller-Hermelink, H. K., Ott, G., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039859 · Cited by 252
Synonymous Mutations and Ribosome Stalling Can Lead to Altered Folding Pathways and Distinct Minima
Tsai, C.-J., Sauna, Z. E., Kimchi-Sarfaty, C., Ambudkar, S. V., Gottesman, M. M., & Nussinov, R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.012 · Cited by 252
Antoniou, A. C., Sinilnikova, O. M., Simard, J., Léoné, M., Dumont, M., Neuhausen, S. L., Struewing, J. P., Stoppa-Lyonnet, D., Barjhoux, L., Hughes, D. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522611 · Cited by 241
TERT promoter mutations in cancer development
Heidenreich, B., Rachakonda, P. S., Hemminki, K., & Kumar, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.005 · Cited by 238
Recurrent somatic mutations in regulatory regions of human cancer genomes
Melton, C., Reuter, J. A., Spacek, D. V., & Snyder, M. (2015) · Nature Genetics · doi:10.1038/ng.3332 · Cited by 236
The H19 gene: regulation and function of a non-coding RNA
Gabory, A., Ripoche, M.-A., Yoshimizu, T., & Dandolo, L. (2006) · Cytogenetic and Genome Research · doi:10.1159/000090831 · Cited by 227
A new type of mutation causes a splicing defect in ATM
Pagani, F., Buratti, E., Stuani, C., Bendix, R., Dörk, T., & Baralle, F. E. (2002) · Nature Genetics · doi:10.1038/ng858 · Cited by 217
Splicing of Messenger RNA Precursors
Sharp, P. A., Konarksa, M. M., Grabowski, P. J., Lamond, A. I., Marciniak, R., & Seiler, S. R. (1987) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1987.052.01.033 · Cited by 216
Bartoszewski, R. A., Jablonsky, M., Bartoszewska, S., Stevenson, L., Dai, Q., Kappes, J., Collawn, J. F., & Bebok, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154575 · Cited by 202
FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
Dong, X.-Y., Rodriguez, C., Guo, P., Sun, X., Talbot, J. T., Zhou, W., Petros, J., Li, Q., Vessella, R. L., Kibel, A. S., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm375 · Cited by 200
Implication of snoRNA U50 in human breast cancer
Dong, X.-Y., Guo, P., Boyd, J., Sun, X., Li, Q., Zhou, W., & Dong, J.-T. (2009) · Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60134-4 · Cited by 199
Oh, H.-K., Tan, A. L.-K., Das, K., Ooi, C.-H., Deng, N.-T., Tan, I. B., Beillard, E., Lee, J., Ramnarayanan, K., Rha, S.-Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3152 · Cited by 199
Piwi-interacting RNAs in cancer: emerging functions and clinical utility
Ng, K. W., Anderson, C., Marshall, E. A., Minatel, B. C., Enfield, K. S. S., Saprunoff, H. L., Lam, W. L., & Martinez, V. D. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0491-9 · Cited by 196
Long Non-Coding RNAs: Challenges for Diagnosis and Therapies
Sánchez, Y., & Huarte, M. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0414 · Cited by 187
Lerner, M., Harada, M., Lovén, J., Castro, J., Davis, Z., Oscier, D., Henriksson, M., Sangfelt, O., Grandér, D., & Corcoran, M. M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.001 · Cited by 179
The efficiency of folding of some proteins is increased by controlled rates of translation in vivo
Purvis, I. J., Bettany, A. J. E., Santiago, T. C., Coggins, J. R., Duncan, K., Eason, R., & Brown, A. J. P. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90230-0 · Cited by 178
Diederichs, S., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0537 · Cited by 176
Self-citationPosttranscriptional Regulation of Gene Expression by Piwi Proteins and piRNAs
Watanabe, T., & Lin, H. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.012 · Cited by 173
Busslinger, M., Klix, N., Pfeffer, P., Graninger, P. G., & Kozmik, Z. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6129 · Cited by 169
Martinez, V. D., Vucic, E. A., Thu, K. L., Hubaux, R., Enfield, K. S. S., Pikor, L. A., Becker-Santos, D. D., Brown, C. J., Lam, S., & Lam, W. L. (2015) · Scientific Reports · doi:10.1038/srep10423 · Cited by 169
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma
Gartner, J. J., Parker, S. C. J., Prickett, T. D., Dutton-Regester, K., Stitzel, M. L., Lin, J. C., Davis, S., Simhadri, V. L., Jha, S., Katagiri, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304227110 · Cited by 168
Fu, A., Jacobs, D., Hoffman, A. E., Zheng, T., & Zhu, Y. L. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv105 · Cited by 163
Schödel, J., Bardella, C., Sciesielski, L. K., Brown, J. M., Pugh, C. W., Buckle, V., Tomlinson, I. P., Ratcliffe, P. J., & Mole, D. R. (2012) · Nature Genetics · doi:10.1038/ng.2204 · Cited by 158
Raponi, M., Královičová, J., Copson, E., Divina, P., Eccles, D., Johnson, P., Baralle, D., & Vořechovský, I. (2011) · Human Mutation · doi:10.1002/humu.21458 · Cited by 153
A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype
Occhi, G., Regazzo, D., Trivellin, G., Boaretto, F., Ciato, D., Bobisse, S., Ferasin, S., Cetani, F., Pardi, E., Korbonits, M., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003350 · Cited by 152
for the Bellvitge Colorectal Cancer Study Group, Cox, D. G., Pontes, C., Guinó, E., Navarro, M., Osorio, A., Canzian, F., & Moreno, V. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601906 · Cited by 148
The Search for Infectious Causes of Human Cancers: Where and Why (Nobel Lecture)
Hausen, H. Z. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901917 · Cited by 146
Chappell, S. A., Quesne, J. P. C. L., Paulin, F., deSchoolmeester, M. L., Stoneley, M., Soutar, R. L., Ralston, S. H., Helfrich, M., & Willis, A. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203791 · Cited by 138
Genetic variants in lncRNA HOTAIR are associated with risk of colorectal cancer
Xue, Y., Gu, D., Ma, G., Zhu, L., Hua, Q., Chu, H., Tong, N., Chen, J., Zhang, Z., & Wang, M. (2014) · Mutagenesis · doi:10.1093/mutage/geu076 · Cited by 134
Rothschild, S. I. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-7 · Cited by 133
Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer
Slabý, O., Vašků, J. B., Svoboda, M., & Vyzula, R. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01359.x · Cited by 128
Regulation of mRNA transport, localization and translation in the nervous system of mammals (Review)
Liegro, C. M. D., Schiera, G., & Liegro, I. D. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1629 · Cited by 124
Exon identity crisis: disease-causing mutations that disrupt the splicing code
Sterne-Weiler, T., & Sanford, J. R. (2014) · Genome biology · doi:10.1186/gb4150 · Cited by 123
Liu, D., Guo, H., Li, Y., Xu, X., Yang, K., & Bai, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031251 · Cited by 117
Mechanistic Aspects of COX-2 Expression in Colorectal Neoplasia
Dixon, D. A., Blanco, F. F., Bruno, A., & Patrignani, P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-30331-9_2 · Cited by 114
Kotani, A., Ha, D., Hsieh, J. J., Rao, P., Schotte, D., den Boer, M. D., Armstrong, S., & Lodish, H. (2008) · Blood · doi:10.1182/blood-2008-12-191619 · Cited by 108
Signori, E., Bagni, C., Papa, S., Primerano, B., Rinaldi, M., Amaldi, F., & Fazio, V. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204620 · Cited by 104
13q14 deletions in CLL involve cooperating tumor suppressors
Palamarchuk, A., Efanov, A. A., Nazaryan, N., Santanam, U., Alder, H., Rassenti, L. Z., Kipps, T. J., Croce, C. M., & Pekarsky, Y. (2010) · Blood · doi:10.1182/blood-2009-10-249367 · Cited by 103
Germline mutation of microRNA-125a is associated with breast cancer
Li, W., Duan, R., Kooy, R. F., Sherman, S. L., Zhou, W., & Jin, P. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063123 · Cited by 102
Wang, W., Sun, J., Li, F., Li, R. Q., Gu, Y., Liu, C., Peng, Y., Zhu, M., Chen, L., Tian, W., et al. (2011) · Human Mutation · doi:10.1002/humu.22014 · Cited by 95
Translational Selection Is Ubiquitous in Prokaryotes
Supek, F., Škunca, N., Repar, J., Vlahoviček, K., & Šmuc, T. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001004 · Cited by 94
3’UTR mediated regulation of the cyclin D1 proto-oncogene
Deshpande, A. J., Pastore, A., Deshpande, A. J., Zimmermann, Y., Hutter, G., Weinkauf, M., Buske, C., Hiddemann, W., & Dreyling, M. H. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9993 · Cited by 93
Micro RNA ‐142 is mutated in about 20% of diffuse large B ‐cell lymphoma
Klangbud, W. K., Lenze, D., Alles, J., Motsch, N., Barth, S., Döll, C., Imig, J., Hummel, M., Tinguely, M., Trivedi, P., et al. (2012) · Cancer Medicine · doi:10.1002/cam4.29 · Cited by 85
Petronzelli, F., Sollima, D., Coppola, G., Martini‐Neri, M. E., Neri, G., & Genuardi, M. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1159 · Cited by 82
Anczuków, O., Buisson, M., Léoné, M., Coutanson, C., Lasset, C., Calender, A., Sinilnikova, O. M., & Mazoyer, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1100 · Cited by 80
Zanetti, K. A., Haznadar, M., Welsh, J. A., Robles, A. I., Ryan, B. M., McClary, A. C., Bowman, E. D., Goodman, J. E., Bernig, T., Chanock, S. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3073 · Cited by 77
Griseri, P., Bourcier, C., Hiéblot, C., Essafi‐Benkhadir, K., Chamorey, E., Touriol, C., & Pagès, G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr390 · Cited by 77
Multiple conformations are a conserved and regulatory feature of the RB1 5′ UTR
Kutchko, K. M., Sanders, W., Ziehr, B., Phillips, G., Solem, A., Halvorsen, M., Weeks, K. M., Moorman, N. J., & Laederach, A. (2015) · RNA · doi:10.1261/rna.049221.114 · Cited by 76
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
Ramsingh, G., Koboldt, D. C., Trissal, M. C., Chiappinelli, K. B., Wylie, T., Koul, S., Chang, L., Nagarajan, R., Fehniger, T. A., Goodfellow, P. J., et al. (2010) · Blood · doi:10.1182/blood-2010-05-285395 · Cited by 71
Lazrak, A., Fu, L., Bali, V., Bartoszewski, R., Rab, A., Havasi, V., Keiles, S. B., Kappes, J. C., Kumar, R., Lefkowitz, E. J., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-227330 · Cited by 69
Ma, F., Sun, T., Shi, Y., Yu, D., Tan, W., Yang, M., Wu, C. H., Chu, D.-T., Sun, Y. P., Xu, B., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.12.025 · Cited by 68
Liu, G., Gramling, S. J. B., Munoz, D., Cheng, D., Azad, A. K., Mirshams, M., Chen, Z., Xu, W., Roberts, H. N., Shepherd, F. A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.81 · Cited by 61
A silent mutation in exon 14 of theAPC gene is associated with exon skipping in a FAP family
Montera, M. P., Piaggio, F., Marchese, C. A., Gismondi, V., Stella, A., Resta, N., Varesco, L., Guanti, G., & Mareni, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.12.863 · Cited by 60
Ma, J., DeFrances, M. C., Zou, C., Johnson, C., Ferrell, R. E., & Zarnegar, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36640 · Cited by 60
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
Gerbitz, A., Mautner, J., Geltinger, C., Hörtnagel, K., Christoph, B., Asenbauer, H., Klobeck, G., Polack, A., & Bornkamm, G. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202468 · Cited by 60
Suzairi, M. S. M., Tan, S. C., Aizat, A. A. A., Aminudin, M. M., Nurfatimah, M. S. S., Zakaria, A. D., & Ankathil, R. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.05.007 · Cited by 57
Moshynska, O., Sankaran, K., Pahwa, P., & Saxena, A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh122 · Cited by 57
A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation
Moore, A. E., Young, L. E., & Dixon, D. A. (2011) · Oncogene · doi:10.1038/onc.2011.349 · Cited by 55
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study
Schutz, F. A., Pomerantz, M. M., Gray, K. P., Atkins, M. B., Rosenberg, J. E., Hirsch, M. S., McDermott, D. F., Lampron, M. E., Lee, G. M., Signoretti, S., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70517-x · Cited by 53
Soto, J. L., Cabrera, C. M., Serrano, S., & López‐Nevot, M. Á. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-36 · Cited by 53
Zhang, P., Wei, Q., Li, X., Wang, K., Zeng, H., Bu, H., & Li, H. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.01.017 · Cited by 50
Integrative Analysis of Somatic Mutations Altering MicroRNA Targeting in Cancer Genomes
Ziebarth, J. D., Bhattacharya, A., & Cui, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047137 · Cited by 47
Lehmann, T. P., Korski, K., Ibbs, M., Zawierucha, P., Grodecka-Gazdecka, S., & Jagodziński, P. P. (2012) · Oncology Letters · doi:10.3892/ol.2012.1040 · Cited by 43
Schneider, S. A., Wildhardt, G., Ludwig, R., & Royer‐Pokora, B. (1993) · Human Genetics · doi:10.1007/bf00205087 · Cited by 43
Effect of a natural mutation in the 5′ untranslated region on the translational control of p53 mRNA
Khan, D., Sharathchandra, A., Ponnuswamy, A., Grover, R., & Das, S. (2012) · Oncogene · doi:10.1038/onc.2012.422 · Cited by 42
Staropoli, J. F., Li, H., Chun, S. J., Allaire, N., Cullen, P. F., Thai, A., Fleet, C., Hua, Y., Bennett, C. F., Krainer, A. R., et al. (2015) · Genomics · doi:10.1016/j.ygeno.2015.01.007 · Cited by 42
Somers, J., Wilson, L. A., Kilday, J., Horvilleur, E., Cannell, I. G., Pöyry, T. A. A., Cobbold, L. C., Kondrashov, A., Knight, J. R. P., Puget, S., et al. (2015) · Genes & Development · doi:10.1101/gad.261867.115 · Cited by 42
Unclassified variants identified in BRCA1 exon 11: Consequences on splicing
Anczuków, O., Buisson, M., Salles, M., Triboulet, S., Longy, M., Lidereau, R., Sinilnikova, O. M., & Mazoyer, S. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20546 · Cited by 41
Wang, A., Xu, B., Tong, N., Chen, S.-Q., Yang, Y., Zhang, X.-W., Jiang, H., Liu, N., Liu, J., Hu, X.-N., et al. (2012) · Genetics and Molecular Research · doi:10.4238/2012.august.31.2 · Cited by 35
Brown, M. A., Lo, L.-J., Catteau, A. L., Xu, C., Lindeman, G. J., Hodgson, S. V., & Solomon, E. (2002) · Human Mutation · doi:10.1002/humu.10055 · Cited by 34
The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping
Hansen, T. V. O., Steffensen, A. Y., Jønson, L., Andersen, M. K., Ejlertsen, B., & Nielsen, F. C. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0359-4 · Cited by 33
Zhang, X., Leav, I., Revelo, M. P., Deka, R., Medvedovic, M., Jiang, Z., & Ho, S. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000334 · Cited by 30
Ideraabdullah, F., Thorvaldsen, J. L., Myers, J. A., & Bartolomei, M. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu344 · Cited by 30
Novel Intronic Mutation of MEN1 Gene Causing Familial Isolated Primary Hyperparathyroidism
Carrasco, C. A., González, A. A., Carvajal, C. A., Campusano, C., Oestreicher, E. M., Arteaga, E., Nelson Wohllk, G., & Fardella, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032101 · Cited by 30
Gong, Z., Bostick, R. M., Xie, D., Hurley, T. G., Deng, Z.-L., Dixon, D. A., Zhang, J., & Hébert, J. R. (2009) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0656-8 · Cited by 28
Gao, X., Huang, M., Liu, L., He, Y., Yu, Q., Zhao, H., Zhou, C., Zhang, J., Zhu, Z., Wan, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055169 · Cited by 26
KRAS alleles: The LCS6 3′UTR variant and KRAS coding sequence mutations in the NCI-60 panel
Kundu, S. T., Nallur, S. V., Paranjape, T., Boeke, M., Weidhaas, J. B., & Slack, F. J. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18794 · Cited by 24
Vidal, C., Cachia, A., & Xuereb‐Anastasi, A. (2009) · Bone · doi:10.1016/j.bone.2009.06.027 · Cited by 24
Gewirtz, A. M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-777-2_2 · Cited by 23
Pinto, E. M., Ribeiro, R. C., Kletter, G. B., Lawrence, J. P., Jenkins, J. J., Wang, J., Shurtleff, S. A., McGregor, L. M., Kriwacki, R. W., & Zambetti, G. P. (2010) · Familial Cancer · doi:10.1007/s10689-010-9392-z · Cited by 22
Wang, J., Lü, C., Min, D., Wang, Z., & Ma, X. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500417 · Cited by 21
Report on mutation in exon 15 of the APC gene in a case of brain metastasis
Pećina‐Šlaus, N., Majić, Ž., Musani, V., Zeljko, M., & Čupić, H. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0001-7 · Cited by 17
Alternative Polyadenylation of Tumor Suppressor Genes in Small Intestinal Neuroendocrine Tumors
Rehfeld, A., Plass, M., Døssing, K. B. V., Knigge, U., Kjær, A., Krogh, A., & Friis-Hansen, L. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00046 · Cited by 16
Sánchez‐Sánchez, F., Krützfeldt, M., Nájera, C., & Mittnacht, S. (2005) · Human Mutation · doi:10.1002/humu.9305 · Cited by 8
Piao, J., Sakurai, N., Iwamoto, S., Nishioka, J., Nakatani, K., Komada, Y., Mizutani, S., & Takagi, M. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21912 · Cited by 7
Fujita, J., Dohmoto, K., Hojo, S., et al. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00271-9 · Cited by 4
Cited by
RNA Structural Dynamics As Captured by Molecular Simulations: A Comprehensive Overview
Šponer, J., Bussi, G., Krepl, M., Banáš, P., Bottaro, S., Cunha, R. A., Gil-Ley, A., Pinamonti, G., Poblete, S., Jurečka, P., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00427 · Cited by 599
Translational Control in Cancer
Robichaud, N., Sonenberg, N., Ruggero, D., & Schneider, R. J. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032896 · Cited by 302
The HUSH complex cooperates with TRIM28 to repress young retrotransposons and new genes
Robbez-Masson, L., Tie, C. H. C., Conde, L., Tunbak, H., Husovsky, C., Tchasovnikarova, I. A., Timms, R. T., Herrero, J., Lehner, P. J., & Rowe, H. M. (2018) · Genome Research · doi:10.1101/gr.228171.117 · Cited by 221
Archaic adaptive introgression in TBX15/WARS2
Racimo, F., Gokhman, D., Fumagalli, M., Ko, A., Hansen, T., Moltke, I., Albrechtsen, A., Carmel, L., Huerta-Sánchez, E., & Nielsen, R. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw283 · Cited by 101
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers
Kobayashi, Y., Chhoeu, C., Li, J., Price, K. S., Kiedrowski, L. A., Hutchins, J. L., Hardin, A. I., Wei, Z., Hong, F., Bahcall, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04451-4 · Cited by 56
Metadata
- Authors
- Diederichs, S., Bartsch, L., Berkmann, J. C., Fröse, K., Heitmann, J., Hoppe, C., Iggena, D., Jazmati, D., Karschnia, P., Linsenmeier, M., Maulhardt, T., Möhrmann, L., Morstein, J., Paffenholz, S. V., Röpenack, P., Rückert, T., Sandig, L., Schell, M., Steinmann, A., Voss, G., Wasmuth, J., Weinberger, M. E., & Wullenkord, R.
- Venue
- EMBO Molecular Medicine
- Published
- 2016-03-18
- Volume
- 8
- Issue
- 5
- Pages
- 442-457
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2296948836
- Cited by
- 253
- References
- 169
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.